Latest

antidepressants

·July 10, 2025·7 min read

Most Antidepressant Users Don’t Face Severe Withdrawal

The largest review of antidepressant withdrawal studies shows most people don’t experience severe symptoms when stopping these medications. Analyzing data from nearly 18,000 participants, researchers found the most common withdrawal symptoms were mild, including dizziness, nausea, and nervousness.

Featured Neurology Neuroscience

·May 30, 2025·4 min read

SSRIs Restore Brain Function in Alzheimer’s

A new study suggests that SSRIs, commonly prescribed antidepressants, may reduce biological markers of Alzheimer’s disease. In a cohort of 191 individuals, AD patients on SSRIs had lower levels of plasma phosphorylated tau-181, a key indicator of disease severity.

Featured Neuroscience Psychology

·May 24, 2025·4 min read

Boosting Ketamine’s Antidepressant Effects to Last Two Months

Ketamine is a fast-acting antidepressant that can relieve symptoms of major depressive disorder (MDD) within hours, even in treatment-resistant cases. However, its effects typically last only a week, and frequent dosing poses risks like dissociation or addiction.

Neuroscience

·May 22, 2025·6 min read

Long-Term Antidepressant Use Tied to Tougher Withdrawal Symptoms

A new study finds that people who have taken antidepressants for more than two years are significantly more likely to experience withdrawal symptoms when stopping the medication. The longer someone used antidepressants, the more severe and prolonged the symptoms became, with 64% of long-term users reporting moderate or severe withdrawal.

Featured Neuroscience Psychology

·May 7, 2025·8 min read

SSRI Exposure in the Womb May Rewire Brain Circuits

New research suggests that prenatal exposure to SSRIs may alter brain development in ways that increase the risk of depression and anxiety later in life. Using mice and human data, scientists found that early-life SSRI exposure heightened activity in brain fear circuits, a pattern not observed in offspring of depressed mothers who did not take SSRIs.

Featured Neuroscience Psychology

·April 23, 2025·6 min read

Can Brain Scans Tell Which Antidepressant Will Work for You?

A new study shows that brain connectivity patterns, especially in the dorsal anterior cingulate cortex, can help predict how patients with major depressive disorder (MDD) will respond to antidepressants. By combining brain imaging with clinical data, researchers developed machine learning models that accurately predicted treatment outcomes across two large trials.

Featured Neuroscience Psychology

·April 4, 2025·3 min read

How Psilocybin Lifts Mood Without the Hallucinogenic Trip

Researchers have uncovered two key brain mechanisms—specific neurons and a serotonin receptor—that help explain how psilocybin produces long-lasting antidepressant effects. Their study identified pyramidal tract neurons in the medial frontal cortex and the serotonin 5-HT2A receptor as essential to the therapeutic action of psilocybin.

Featured Neuroscience Psychology

·February 25, 2025·3 min read

SSRIs May Speed Up Cognitive Decline

A new study based on data from 18,740 dementia patients suggests that antidepressants may accelerate cognitive decline. Researchers found that patients taking antidepressants, particularly SSRIs like escitalopram, citalopram, and sertraline, experienced faster deterioration compared to those not on medication.

Featured Neuroscience Psychology

·February 14, 2025·4 min read

How Ketamine Binds to Brain Receptors to Alter Mood

New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D. Scientists used electron cryo-microscopy to capture how ketamine binds to this receptor, revealing multiple attachment sites that influence brain activity.

Featured Neuroscience Psychology

·February 14, 2025·6 min read

Prozac Shows Promise in Fighting Infections & Sepsis

New research suggests that fluoxetine, commonly used as an antidepressant, may also help protect against infections and sepsis. Scientists found that the drug has antimicrobial properties and helps regulate the immune response, reducing the risk of tissue and organ damage.

Featured Neuroscience Psychology

·December 12, 2024·8 min read

Gut Serotonin Plays Role in Depression and Mood

Serotonin in the gut epithelium plays a critical role in modulating mood and may provide a safer target for treating depression and anxiety. In animal studies, increasing gut serotonin improved mood symptoms without causing digestive issues, unlike systemic antidepressant treatments.

Brain Cancer Featured Neurology Neuroscience

·September 22, 2024·5 min read

Antidepressant May Help Fight Glioblastoma Brain Tumors

Researchers have discovered that the antidepressant vortioxetine effectively combats glioblastoma, a deadly brain tumor, in lab tests and in mice. This drug, already FDA-approved, crosses the blood-brain barrier and could potentially improve treatment for glioblastoma patients when combined with standard therapy.

1 2 3 … 20

antidepressants

Most Antidepressant Users Don’t Face Severe Withdrawal

SSRIs Restore Brain Function in Alzheimer’s

Boosting Ketamine’s Antidepressant Effects to Last Two Months

Long-Term Antidepressant Use Tied to Tougher Withdrawal Symptoms

SSRI Exposure in the Womb May Rewire Brain Circuits

Can Brain Scans Tell Which Antidepressant Will Work for You?

How Psilocybin Lifts Mood Without the Hallucinogenic Trip

SSRIs May Speed Up Cognitive Decline

How Ketamine Binds to Brain Receptors to Alter Mood

Prozac Shows Promise in Fighting Infections & Sepsis

Gut Serotonin Plays Role in Depression and Mood

Antidepressant May Help Fight Glioblastoma Brain Tumors

Gene Key to MS Immune Regulation Discovered

Maternal Depression Linked to Weaker Bonds

Study Challenges Link Between Football and Brain Protein Buildup

Spotting Silent Scars: A New Way to Detect Childhood Abuse

Subscribe